Ernexa Therapeutics Inc. Warrants (ERNAW)

NASDAQ

$0.16

-$0.01 (5.88%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$0.13$0.19

Open $0.19

52 Week Range

$0.14$0.19

Previous Close $0.17

Market Cap1.26M

Volume92.42K

Avg Volume38.03K

P/E (TTM)N/A

EPS (TTM)N/A

Dividend / YieldN/A

Dividend StreakN/A

About Ernexa Therapeutics Inc. Warrants

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Company Info

SectorFinancial Services

IndustryAsset Management

CEOSanjeev Luther

Employees6

Websitewww.ernexatx.com

Trading Information

Open

$0.19

Previous Close

$0.17

Day High

$0.19

Day Low

$0.13

52 Week High

$0.19

52 Week Low

$0.14

About Ernexa Therapeutics Inc. Warrants

Company Info

SectorFinancial Services

IndustryAsset Management

CEOSanjeev Luther

Employees6

Websitewww.ernexatx.com

Trading Information

Open

$0.19

Previous Close

$0.17

Day High

$0.19

Day Low

$0.13

52 Week High

$0.19

52 Week Low

$0.14